DDX5 and colorectal carcinoma: A recent study demonstrated that DDX5 could mediate the mRNA stabilization of PHGDH, a key enzyme in the serine synthesis pathway, leading to nucleotide metabolic reprogramming to promote CRC progression and chemoresistance (21) (Figure 2).